Posts Tagged: pharmacy

Free COVID-19 Resources for Pharmacy

covid-19 resources

As a partner to the pharmacy community, we understand the critical role you play in the COVID-19 response. As a first line of contact for many individuals, pharmacies can deliver important and vital information regarding COVID-19. To help you communicate and provide factual information, we’re offering free COVID-19 resources.

COVID-19 Resources: Why the Facts Matter

As with any scenario in the modern world, there’s a cloud of misinformation surrounding COVID-19. The world is also seeing changes in guidelines around how to protect yourself. This includes the recent new guidance of encouraging all to wear cloth masks over their nose and mouth in public. Previously, face masks were only deemed necessary for those sick or interacting with infected patients. 

We looked at the guidelines provided by the CDC to develop resources for you to place in your pharmacy, as well as share on your social media profiles. By being a source for consistent and reliable information, your customers will be better prepared for facing life during the pandemic.

Other Ways to Communicate with Patients

In addition to offering free posters and social media posts, our pharmacy print division, Printwerks, can also design, print, and mail first-class letters to patients. These services provide a way to stay connected with patients. 

These branded letters enable you to communicate how you’re responding to COVID-19, such as offering more flexible delivery or curbside pickup. It’s also another channel to disperse COVID-19 facts. In a time when patients are worried about prescription drug access and availability, you can reassure them of your ability to take care of them.

Getting Your Free Resources Is Easy

It only takes a few minutes to get your free resources. You’ll simply submit your information and receive two posters and two social media posts with your logo. There is no cost for this service. It’s just our way of saying thank you to all the pharmacy teams working tirelessly to make a difference.

To claim your free resources, visit our setup page today. If you have any questions, contact us at emma@infowerks.com or call us at 702-914-9910.

The Role of Pharmacy in the COVID-19 Outbreak

role of pharmacy in covid-19

The healthcare ecosystem is on the frontlines of fighting coronavirus. Each stakeholder plays an essential role in responding to the virus. That includes pharmacists. The role of pharmacy in the COVID-19 outbreak is evolving and changing, providing critical ways to help mitigate the spread, deliver medications, and assisting with testing.

HHS Authorizes Pharmacists for COVID-19 Testing

On April 8, HHS issued a statement that authorizes licensed pharmacists to order and administer COVID-19 tests. With this one decision, pharmacists can now provide easier access to testing. By doing so, pharmacists are now able to speed up diagnosis. This can lead to earlier treatment and reduce the chance that the person will infect others. 

Pharmacists have long acted as counsel to patients. They’ve been a key player in immunizations as well. This new ability to test for COVID-19 allows them to make a difference in their patients’ health.

Shortages Are Becoming More Common

drug shortages covid-19

Drug shortages have been an emerging fear for patients and the healthcare community. These concerns include the increased demand for medications that can treat COVID-19 as well as the medication taken for chronic conditions. 

Some reports have actually found these two points converging. Those with autoimmune diseases, like lupus, are now facing shortages. Hydroxychloroquine is a prescription that helps those with lupus fight off flares. It’s now been making headlines because it may be a possible treatment for coronavirus. Patients are scared they’ll be cut off because of new demand.

Supply, Demand, and 90-Day Fills

Further, pharmacists are also facing new requests for those with chronic diseases, asking for 90-day supplies due to the concern with needing to shelter in place. The problem many may be facing is that not all insurance providers allow 90-day fills for medications.

It’s a perfect storm of concerns with access, demand, and supply. Finding new suppliers is challenging and often comes with a heftier price tag. As the role of pharmacy in the COVID-19 pandemic grows, each pharmacy must contend with ensuring that their patients have the medications they need. 

What Pharmacists Need to Address Operational Challenges and Care Continuity

Pharmacy organizations issued a joint policy recommendation to enable pharmacists to do more. To address the issue of shortages in medication and workforce, these groups have requested a relaxation of operational barriers. 

In short, they want to introduce flexible staffing that allows pharmacists and techs to work across state lines, open satellite locations in pharmacy deserts, and waive limitations on who can staff the pharmacy. Additionally, they have called for the ability to provide early refills and more 90-day supplies. 

When looking at the shortage of medication issues, pharmacists would like to be able to allow therapeutic interchange and substitution. Further, they want expiration dates extended and more transparency from the FDA about supply chain shortages.

With these changes, pharmacists can be better prepared to keep serving their communities.

Keeping Patients Informed

As a direct point of access for many patients, pharmacists have become providers of information as well. Many pharmacies are using different channels to communicate with patients. That includes signage at stores that offer advice from the medical community or sending communications to patients to update them on how their response to the virus. Patients need to hear from pharmacists now. This reassurance could minimize their worries.

Sharing Data: Essential in Tracking the Virus

pharmacy covid-19

The ability to share pharmacy data without different entities could offer the healthcare community more insight. The HHS announcement did not provide any details on how pharmacies will share test results. While they are likely to submit them to government entities like HHS and the CDC, other studies may benefit from them as well. 

Currently, John’s Hopkins has a coronavirus tracker, which provides information by state. There is also an IHME Model, which projects hospital resource use. Researchers and experts at multiple pharmaceutical and healthcare companies are scrambling to create a vaccine, and pharmacy data could help. 

The pharmacy data of prescriptions for those with COVID-19 could deliver key information to learning what’s working and what isn’t. Data sharing is a critical need right now, as we all come to understand the virus better. 

Pharmacy on the Frontlines

As with any healthcare emergency, each segment of the industry has a role to play. Pharmacists just like physicians, nurses, and other clinicians, are on the frontlines of COVID-19. As a partner to the healthcare community, we appreciate all you do. We’re here to support you along the way. 

HHS Interoperability Rule Omits Key Stakeholder—Pharmacy

hhs interoperability rule

The new HHS interoperability rule will forever change the world of healthcare data. HHS adopted the new rules based on three major objectives: providing better access to healthcare records for patients, eradicating information blocking, and improving care coordination. While the rule is inclusive to and applicable to many key stakeholders—patients, providers, payers, and EHR vendors. It leaves out a significant player in the healthcare ecosystem—pharmacy.

Why Pharmacy Deserves a Seat at the Table

Patients should certainly have access to all their healthcare data. The HHS interoperability rule mandates that this occur. The pressure is on providers and payers to offer easy access, but it doesn’t include the entire circle of care. Healthcare records from physicians typically include prescriptions, but there is no confirmation within these records that the patient picked up or began the medication prescribed.

Pharmacy systems have this data. They have a complete view of a patient’s prescription history across all providers. This data also includes that they actually picked up the prescription. This is important because patients don’t always adhere to the medication regimen. Further, many patients get to the pharmacy, only to learn their insurance doesn’t cover the medication. This scenario may never make it back to their physician.

With this in mind, pharmacy deserves a seat at the table.

Care Coordination and Medication Adherence

medication adherence

Several requirements of the interoperability rule relate to care coordination. First, all hospitals will be required to send notifications of a patient’s admission, discharge, or transfer. In an effort to improve care coordination and care continuity, communication is vital. 

Care coordination has long been a challenge in healthcare. The healthcare system is fractured and disjointed. Establishing a new Condition of Participation (CoP) should support coordination of care while also decreasing readmissions. 

But how can you coordinate all areas of care without having pharmacy in the discussion? Roughly speaking, medication non-adherence leads to over 125,000 preventable deaths each year and over $300 billion in avoidable costs. Further, one in five Medicare patients is readmitted to the hospital within 30 days; half of them due to non-adherence.

So, how is healthcare going to tackle this without the support and coordination of pharmacy?

Pharmacy Often Left Out of Healthcare Policy

This rule isn’t the first time that pharmacy has been excluded from the conversation. Not until recently were pharmacists invited to play a role in opioid task forces! Unbelievable but very true. At the root of healthcare, there are central pillars that allow physicians to treat patients, including labs, physical therapy, and pharmacy. 

Providers, payers, and HHS could learn some critical insights from pharmacy about medication adherence and how to improve it for care continuity. Pharmacy absolutely deserves to be part of the new interoperability rule because they play a vital role in treating patients. 

What do you think? Should HHS have consulted the pharmacy industry on the new rules?